Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Current Leases (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Current Leases over the past 3 years, most recently at $125000.0 for Q4 2025.

  • Quarterly results put Current Leases at $125000.0 for Q4 2025, down 54.38% from a year ago — trailing twelve months through Dec 2025 was $125000.0 (down 54.38% YoY), and the annual figure for FY2025 was $125000.0, down 54.38%.
  • Current Leases for Q4 2025 was $125000.0 at Tonix Pharmaceuticals Holding, down from $159000.0 in the prior quarter.
  • Over the last five years, Current Leases for TNXP hit a ceiling of $438000.0 in Q1 2023 and a floor of $125000.0 in Q4 2025.
  • Median Current Leases over the past 3 years was $274500.0 (2024), compared with a mean of $282916.7.
  • Biggest five-year swings in Current Leases: grew 1.48% in 2024 and later crashed 54.38% in 2025.
  • Tonix Pharmaceuticals Holding's Current Leases stood at $270000.0 in 2023, then grew by 1.48% to $274000.0 in 2024, then crashed by 54.38% to $125000.0 in 2025.
  • The last three reported values for Current Leases were $125000.0 (Q4 2025), $159000.0 (Q3 2025), and $195000.0 (Q2 2025) per Business Quant data.